The Impact of Melatonin Lotion on Sleep and Mental Health
Part of paid clinical trials in Redlands, California.
- Sponsor
- University of Redlands
- Study ID
- NCT06768749
- Status
- Recruiting
Conditions
- Depressive Disorder and Anxiety Disorders
- Sleep Problems
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 21 Years
- Healthy Volunteers
- Not accepted
Interventions
- Melatonin lotion — OTHER3 g lotion applied one hour before bedtime
- Placebo lotion — OTHER3 g of placebo lotion (scent-matched control) applied one hour before bedtime
Study Details
The purpose of this study is to examine the effect that melatonin lotion has on sleep quality, the nervous system, and mental health. Melatonin is a hormone secreted by the brain that regulates sleep and might improve depression and anxiety symptoms. The goal is to determine whether melatonin in lotion form is an effective treatment for young adults with inadequate sleep and might improve mental health. Participants will fill out surveys, wear an actigraph (a wrist-worn device that measures sleep), wear a heart rate monitor (a strap worn around one's chest), and provide nightly saliva samples during treatment weeks. In one of the two treatment weeks, participants will receive a lotion that contains melatonin. During the other week they will receive a control treatment that will be lotion with no melatonin, and there will be a week in between with no treatment at all.
Key Dates
- Start date
- Feb 28, 2025
- Status verified
- Apr 2026
- Primary completion
- Apr 1, 2028
- Completion
- Apr 1, 2028
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Melatonin lotion firstParticipants will be randomized to one week of treatment with melatonin lotion, followed by a week washout, then one week of treatment with placebo lotion
- Experimental: Placebo lotion firstParticipants will be randomized to one week of treatment with placebo lotion, followed by a week washout, then one week of treatment with melatonin lotion
Primary Outcome Measure
Sleep disturbance [ Time Frame: Measured pre-treatment, at end of placebo week, and at end of active treatment week (3 weeks total) ]
Central Contacts
- Lisa E Olson, Ph.D.909-748-8524
- Steven Moore, Ph.D.(909) 748-8687
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Redlands | Redlands | California | 92374 | Lisa Olson, Ph.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Redlands, CA
Related Studies
- Use of CBD in the Treatment of AnxietyPHASE2 · Recruiting · University of Florida · Gainesville, Florida
- A Clinical Trial of Iron Supplementation for Youth With ADHD and Restless SleepPHASE1/PHASE2 · Not Yet Recruiting · Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · Baltimore, Maryland
- Sleep Treatment for Teens (RCT Phase)Recruiting · Rutgers, The State University of New Jersey · Piscataway, New Jersey